| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transcription coregulator activity | 1.30e-05 | 562 | 40 | 8 | GO:0003712 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | 2.89e-05 | 303 | 40 | 6 | GO:0003713 | |
| GeneOntologyMolecularFunction | transcription factor binding | 1.04e-04 | 753 | 40 | 8 | GO:0008134 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | 1.10e-04 | 560 | 40 | 7 | GO:0001228 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | 1.17e-04 | 566 | 40 | 7 | GO:0001216 | |
| GeneOntologyMolecularFunction | nuclear receptor coactivator activity | 2.47e-04 | 61 | 40 | 3 | GO:0030374 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | 3.61e-04 | 1412 | 40 | 10 | GO:0000981 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | 3.89e-04 | 1160 | 40 | 9 | GO:0030674 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | 6.47e-04 | 1244 | 40 | 9 | GO:0000978 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | 7.56e-04 | 1271 | 40 | 9 | GO:0000987 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | 1.20e-03 | 1356 | 40 | 9 | GO:0060090 | |
| GeneOntologyMolecularFunction | ubiquitin binding | 1.28e-03 | 107 | 40 | 3 | GO:0043130 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2.00e-03 | 1459 | 40 | 9 | GO:0000977 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein binding | 2.14e-03 | 128 | 40 | 3 | GO:0032182 | |
| GeneOntologyMolecularFunction | bHLH transcription factor binding | 2.49e-03 | 37 | 40 | 2 | GO:0043425 | |
| GeneOntologyMolecularFunction | chromatin binding | 3.30e-03 | 739 | 40 | 6 | GO:0003682 | |
| GeneOntologyMolecularFunction | histone H3 methyltransferase activity | 3.51e-03 | 44 | 40 | 2 | GO:0140938 | |
| GeneOntologyMolecularFunction | core promoter sequence-specific DNA binding | 5.43e-03 | 55 | 40 | 2 | GO:0001046 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein ligase binding | 5.58e-03 | 358 | 40 | 4 | GO:0044389 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | 5.86e-03 | 582 | 40 | 5 | GO:0140297 | |
| GeneOntologyMolecularFunction | phosphoprotein phosphatase activity | 6.38e-03 | 189 | 40 | 3 | GO:0004721 | |
| GeneOntologyMolecularFunction | histone methyltransferase activity | 8.91e-03 | 71 | 40 | 2 | GO:0042054 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | CARM1 RFX6 NR4A1 RUNX2 SSBP4 SSBP3 EGR1 NFATC3 PPRC1 SUPT5H NFIC SMAD5 PRRX2 | 1.21e-06 | 1390 | 40 | 13 | GO:0045944 |
| GeneOntologyBiologicalProcess | protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway | 3.02e-06 | 15 | 40 | 3 | GO:0043328 | |
| GeneOntologyBiologicalProcess | late endosome to vacuole transport via multivesicular body sorting pathway | 1.91e-05 | 27 | 40 | 3 | GO:0032511 | |
| GeneOntologyBiologicalProcess | connective tissue development | 4.82e-05 | 343 | 40 | 6 | GO:0061448 | |
| GeneOntologyBiologicalProcess | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway | 5.02e-05 | 37 | 40 | 3 | GO:0043162 | |
| GeneOntologyBiologicalProcess | osteoblast fate commitment | 5.47e-05 | 6 | 40 | 2 | GO:0002051 | |
| GeneOntologyBiologicalProcess | late endosome to vacuole transport | 5.88e-05 | 39 | 40 | 3 | GO:0045324 | |
| GeneOntologyBiologicalProcess | endosome transport via multivesicular body sorting pathway | 7.90e-05 | 43 | 40 | 3 | GO:0032509 | |
| GeneOntologyBiologicalProcess | membrane fission | 1.10e-04 | 48 | 40 | 3 | GO:0090148 | |
| GeneOntologyBiologicalProcess | multivesicular body sorting pathway | 1.32e-04 | 51 | 40 | 3 | GO:0071985 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | MAP3K10 TSG101 RUNX2 EGR1 NFATC3 SUPT5H NFIC SMAD5 YLPM1 ARID5B | 2.59e-04 | 1399 | 40 | 10 | GO:0045892 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | MAP3K10 TSG101 RUNX2 EGR1 NFATC3 SUPT5H NFIC SMAD5 YLPM1 ARID5B | 2.80e-04 | 1413 | 40 | 10 | GO:1902679 |
| GeneOntologyBiologicalProcess | establishment of protein localization to vacuole | 2.84e-04 | 66 | 40 | 3 | GO:0072666 | |
| GeneOntologyBiologicalProcess | positive regulation of stem cell proliferation | 3.67e-04 | 72 | 40 | 3 | GO:2000648 | |
| GeneOntologyBiologicalProcess | positive regulation of exosomal secretion | 4.33e-04 | 16 | 40 | 2 | GO:1903543 | |
| GeneOntologyBiologicalProcess | regulation of exosomal secretion | 6.82e-04 | 20 | 40 | 2 | GO:1903541 | |
| GeneOntologyBiologicalProcess | protein localization to vacuole | 6.84e-04 | 89 | 40 | 3 | GO:0072665 | |
| MousePheno | postnatal growth retardation | SLC25A46 MPLKIP PPP1R13B EWSR1 LDB3 ARID1B RUNX2 EGR1 POLR2A HGS ARID5B | 1.10e-05 | 881 | 37 | 11 | MP:0001732 |
| MousePheno | abnormal postnatal growth | SLC25A46 MPLKIP PPP1R13B EWSR1 LDB3 ARID1B RUNX2 EGR1 POLR2A HGS ARID5B | 1.45e-05 | 907 | 37 | 11 | MP:0001731 |
| MousePheno | craniofacial phenotype | TOM1L2 CARM1 MPLKIP EYA4 THPO RUNX2 SSBP3 TRIP6 NFATC3 NFIC SMAD5 ARID5B | 1.37e-04 | 1372 | 37 | 12 | MP:0005382 |
| MousePheno | abnormal craniofacial morphology | TOM1L2 CARM1 MPLKIP EYA4 THPO RUNX2 SSBP3 TRIP6 NFATC3 NFIC SMAD5 ARID5B | 1.37e-04 | 1372 | 37 | 12 | MP:0000428 |
| MousePheno | absent mature ovarian follicles | 1.58e-04 | 40 | 37 | 3 | MP:0001132 | |
| MousePheno | abnormal brain development | 2.15e-04 | 638 | 37 | 8 | MP:0000913 | |
| MousePheno | decreased mitotic index | 2.43e-04 | 9 | 37 | 2 | MP:0004759 | |
| Domain | SSDP_DNA-bd | 1.34e-05 | 3 | 40 | 2 | IPR008116 | |
| Domain | VHS | 1.59e-04 | 9 | 40 | 2 | SM00288 | |
| Domain | VHS_dom | 1.59e-04 | 9 | 40 | 2 | IPR002014 | |
| Domain | VHS | 1.59e-04 | 9 | 40 | 2 | PF00790 | |
| Domain | VHS | 1.59e-04 | 9 | 40 | 2 | PS50179 | |
| Domain | MAD_homology1_Dwarfin-type | 2.91e-04 | 12 | 40 | 2 | IPR003619 | |
| Domain | DWA | 2.91e-04 | 12 | 40 | 2 | SM00523 | |
| Domain | MH1 | 2.91e-04 | 12 | 40 | 2 | PF03165 | |
| Domain | - | 4.61e-04 | 15 | 40 | 2 | 1.10.150.60 | |
| Domain | ARID | 4.61e-04 | 15 | 40 | 2 | PF01388 | |
| Domain | BRIGHT | 4.61e-04 | 15 | 40 | 2 | SM00501 | |
| Domain | ARID_dom | 4.61e-04 | 15 | 40 | 2 | IPR001606 | |
| Domain | ARID | 4.61e-04 | 15 | 40 | 2 | PS51011 | |
| Domain | - | 1.41e-03 | 26 | 40 | 2 | 1.25.40.90 | |
| Domain | LisH | 1.63e-03 | 28 | 40 | 2 | IPR006594 | |
| Domain | LisH | 1.63e-03 | 28 | 40 | 2 | SM00667 | |
| Domain | LISH | 1.63e-03 | 28 | 40 | 2 | PS50896 | |
| Domain | ENTH_VHS | 1.75e-03 | 29 | 40 | 2 | IPR008942 | |
| Domain | p53-like_TF_DNA-bd | 5.75e-03 | 53 | 40 | 2 | IPR008967 | |
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | EWSR1 TSG101 RUNX2 SSBP4 SSBP3 EGR1 NFATC3 SUPT5H NFIC POLR2A SMAD5 | 2.92e-09 | 877 | 40 | 11 | 20211142 |
| Pubmed | PPP1R13B EWSR1 ARID1B EYA4 SSBP4 SSBP3 TRIP6 NFATC3 NFIC HGS SMAD5 YLPM1 ARID5B | 3.84e-09 | 1429 | 40 | 13 | 35140242 | |
| Pubmed | 8.10e-09 | 60 | 40 | 5 | 34761192 | ||
| Pubmed | 1.87e-08 | 261 | 40 | 7 | 33277362 | ||
| Pubmed | 7.13e-08 | 486 | 40 | 8 | 20936779 | ||
| Pubmed | 1.18e-07 | 9 | 40 | 3 | 26456826 | ||
| Pubmed | Impact of cytosine methylation on DNA binding specificities of human transcription factors. | 1.69e-07 | 544 | 40 | 8 | 28473536 | |
| Pubmed | PPP1R13B PTPN23 ARID1B EYA4 TRIP6 TNS1 SUPT5H POLR2A HGS YLPM1 | 2.22e-07 | 1049 | 40 | 10 | 27880917 | |
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | 8.13e-07 | 922 | 40 | 9 | 27609421 | |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | 8.28e-07 | 457 | 40 | 7 | 32344865 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 17182674 | ||
| Pubmed | Integration of Runx and Smad regulatory signals at transcriptionally active subnuclear sites. | 1.29e-06 | 2 | 40 | 2 | 12060751 | |
| Pubmed | Hrs regulates multivesicular body formation via ESCRT recruitment to endosomes. | 1.29e-06 | 2 | 40 | 2 | 12900395 | |
| Pubmed | HIV Gag mimics the Tsg101-recruiting activity of the human Hrs protein. | 1.29e-06 | 2 | 40 | 2 | 12900394 | |
| Pubmed | Distinct roles for Tsg101 and Hrs in multivesicular body formation and inward vesiculation. | 1.29e-06 | 2 | 40 | 2 | 16707569 | |
| Pubmed | Crystallographic and functional analysis of the ESCRT-I /HIV-1 Gag PTAP interaction. | 1.29e-06 | 2 | 40 | 2 | 21070952 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 34480849 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 9466414 | ||
| Pubmed | NFI-C regulates osteoblast differentiation via control of osterix expression. | 1.29e-06 | 2 | 40 | 2 | 24801901 | |
| Pubmed | Widespread Expansion of Protein Interaction Capabilities by Alternative Splicing. | 1.74e-06 | 742 | 40 | 8 | 26871637 | |
| Pubmed | 3.73e-06 | 91 | 40 | 4 | 21194568 | ||
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 35093879 | ||
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 19808888 | ||
| Pubmed | Structure and function of the human transcription elongation factor DSIF. | 3.87e-06 | 3 | 40 | 2 | 10075709 | |
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 26809090 | ||
| Pubmed | The Ewing's sarcoma fusion protein, EWS-FLI, binds Runx2 and blocks osteoblast differentiation. | 3.87e-06 | 3 | 40 | 2 | 20665663 | |
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 7768965 | ||
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 12079286 | ||
| Pubmed | Human nuclear Dicer restricts the deleterious accumulation of endogenous double-stranded RNA. | 3.87e-06 | 3 | 40 | 2 | 24814348 | |
| Pubmed | TSG101 interaction with HRS mediates endosomal trafficking and receptor down-regulation. | 3.87e-06 | 3 | 40 | 2 | 12802020 | |
| Pubmed | Yeast screens identify the RNA polymerase II CTD and SPT5 as relevant targets of BRCA1 interaction. | 3.87e-06 | 3 | 40 | 2 | 18197258 | |
| Pubmed | RUNX2 co-operates with EGR1 to regulate osteogenic differentiation through Htra1 enhancers. | 3.87e-06 | 3 | 40 | 2 | 32324256 | |
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 15573378 | ||
| Pubmed | Genistein promotion of osteogenic differentiation through BMP2/SMAD5/RUNX2 signaling. | 3.87e-06 | 3 | 40 | 2 | 24339730 | |
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 9450929 | ||
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 9858508 | ||
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | 4.14e-06 | 583 | 40 | 7 | 29844126 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 4.38e-06 | 588 | 40 | 7 | 38580884 | |
| Pubmed | 4.53e-06 | 28 | 40 | 3 | 27076431 | ||
| Pubmed | 4.53e-06 | 591 | 40 | 7 | 15231748 | ||
| Pubmed | 6.83e-06 | 32 | 40 | 3 | 19542561 | ||
| Pubmed | 7.16e-06 | 634 | 40 | 7 | 34591612 | ||
| Pubmed | 7.73e-06 | 4 | 40 | 2 | 22966907 | ||
| Pubmed | 7.73e-06 | 4 | 40 | 2 | 17714434 | ||
| Pubmed | 7.73e-06 | 4 | 40 | 2 | 15557274 | ||
| Pubmed | The transcriptional co-regulator Jab1 is crucial for chondrocyte differentiation in vivo. | 7.73e-06 | 4 | 40 | 2 | 23203803 | |
| Pubmed | Interactions of TOM1L1 with the multivesicular body sorting machinery. | 7.73e-06 | 4 | 40 | 2 | 15611048 | |
| Pubmed | Cotranscriptional exon skipping in the genotoxic stress response. | 7.73e-06 | 4 | 40 | 2 | 20972445 | |
| Pubmed | 7.73e-06 | 4 | 40 | 2 | 17014699 | ||
| Pubmed | 7.73e-06 | 4 | 40 | 2 | 17320394 | ||
| Pubmed | 7.73e-06 | 4 | 40 | 2 | 21239498 | ||
| Pubmed | 7.73e-06 | 4 | 40 | 2 | 15999204 | ||
| Pubmed | EGR-1/ASPP1 inter-regulatory loop promotes apoptosis by inhibiting cyto-protective autophagy. | 7.73e-06 | 4 | 40 | 2 | 28594407 | |
| Pubmed | 7.73e-06 | 4 | 40 | 2 | 12391174 | ||
| Pubmed | The peptidyl-prolyl isomerase Pin1 interacts with hSpt5 phosphorylated by Cdk9. | 7.73e-06 | 4 | 40 | 2 | 11575923 | |
| Pubmed | 1.25e-05 | 453 | 40 | 6 | 29656893 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | 1.28e-05 | 1294 | 40 | 9 | 30804502 | |
| Pubmed | 1.29e-05 | 5 | 40 | 2 | 17229889 | ||
| Pubmed | The ESCRT-0 component HRS is required for HIV-1 Vpu-mediated BST-2/tetherin down-regulation. | 1.29e-05 | 5 | 40 | 2 | 21304933 | |
| Pubmed | 1.29e-05 | 5 | 40 | 2 | 27025722 | ||
| Pubmed | 1.29e-05 | 5 | 40 | 2 | 11940650 | ||
| Pubmed | 1.29e-05 | 5 | 40 | 2 | 15240819 | ||
| Pubmed | 1.29e-05 | 5 | 40 | 2 | 27612439 | ||
| Pubmed | FGF-2 enhances Runx-2/Smads nuclear localization in BMP-2 canonical signaling in osteoblasts. | 1.29e-05 | 5 | 40 | 2 | 23559326 | |
| Pubmed | Hgs physically interacts with Smad5 and attenuates BMP signaling. | 1.29e-05 | 5 | 40 | 2 | 16516194 | |
| Pubmed | 1.29e-05 | 5 | 40 | 2 | 24105262 | ||
| Pubmed | Tumor promoter-inducible genes are differentially expressed in the developing mouse. | 1.93e-05 | 6 | 40 | 2 | 3185562 | |
| Pubmed | 1.93e-05 | 6 | 40 | 2 | 35325203 | ||
| Pubmed | 1.93e-05 | 6 | 40 | 2 | 14580347 | ||
| Pubmed | Pyk2 suppresses contextual fear memory in an autophosphorylation-independent manner. | 1.93e-05 | 6 | 40 | 2 | 34529077 | |
| Pubmed | Recruitment of UBPY and ESCRT exchange drive HD-PTP-dependent sorting of EGFR to the MVB. | 1.93e-05 | 6 | 40 | 2 | 23477725 | |
| Pubmed | 1.93e-05 | 6 | 40 | 2 | 25673849 | ||
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | 2.02e-05 | 1038 | 40 | 8 | 26673895 | |
| Pubmed | 2.70e-05 | 7 | 40 | 2 | 15150273 | ||
| Pubmed | 2.70e-05 | 7 | 40 | 2 | 19158374 | ||
| Pubmed | 2.70e-05 | 7 | 40 | 2 | 15509564 | ||
| Pubmed | 2.70e-05 | 7 | 40 | 2 | 11916981 | ||
| Pubmed | 2.70e-05 | 7 | 40 | 2 | 28581508 | ||
| Pubmed | Seizure disorders in mutant mice: relevance to human epilepsies. | 2.70e-05 | 7 | 40 | 2 | 10395577 | |
| Pubmed | 2.70e-05 | 7 | 40 | 2 | 20843790 | ||
| Pubmed | 2.70e-05 | 7 | 40 | 2 | 20691033 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | 2.71e-05 | 1082 | 40 | 8 | 38697112 | |
| Pubmed | 3.55e-05 | 55 | 40 | 3 | 34292881 | ||
| Pubmed | 3.60e-05 | 8 | 40 | 2 | 10531362 | ||
| Pubmed | Tat-SF1 protein associates with RAP30 and human SPT5 proteins. | 3.60e-05 | 8 | 40 | 2 | 10454543 | |
| Pubmed | 3.60e-05 | 8 | 40 | 2 | 24653733 | ||
| Pubmed | TRIP6 regulates neural stem cell maintenance in the postnatal mammalian subventricular zone. | 3.60e-05 | 8 | 40 | 2 | 25044744 | |
| Pubmed | 3.60e-05 | 8 | 40 | 2 | 26317613 | ||
| Pubmed | 3.60e-05 | 8 | 40 | 2 | 10199401 | ||
| Pubmed | Cyclin-dependent kinase control of the initiation-to-elongation switch of RNA polymerase II. | 3.60e-05 | 8 | 40 | 2 | 23064645 | |
| Pubmed | 3.60e-05 | 8 | 40 | 2 | 16327805 | ||
| Pubmed | 3.60e-05 | 8 | 40 | 2 | 12612062 | ||
| Pubmed | 3.66e-05 | 549 | 40 | 6 | 38280479 | ||
| Pubmed | 4.62e-05 | 9 | 40 | 2 | 17174262 | ||
| Pubmed | 4.62e-05 | 9 | 40 | 2 | 23222715 | ||
| Pubmed | GATA4 is essential for bone mineralization via ERα and TGFβ/BMP pathways. | 4.62e-05 | 9 | 40 | 2 | 24932701 | |
| Pubmed | 4.62e-05 | 9 | 40 | 2 | 16613856 | ||
| Pubmed | p53 regulates neural stem cell proliferation and differentiation via BMP-Smad1 signaling and Id1. | 4.62e-05 | 9 | 40 | 2 | 23199293 | |
| Pubmed | UBAP1 is a component of an endosome-specific ESCRT-I complex that is essential for MVB sorting. | 4.62e-05 | 9 | 40 | 2 | 21757351 | |
| Pubmed | 4.62e-05 | 9 | 40 | 2 | 23344708 | ||
| Interaction | EP300 interactions | CARM1 PPP1R13B EWSR1 TSG101 EYA4 THPO NR4A1 RUNX2 SSBP4 MOGS EGR1 SUPT5H POLR2A SMAD5 YLPM1 | 3.04e-08 | 1401 | 40 | 15 | int:EP300 |
| Interaction | SNRPC interactions | 1.56e-07 | 440 | 40 | 9 | int:SNRPC | |
| Interaction | NCOA3 interactions | 2.60e-07 | 224 | 40 | 7 | int:NCOA3 | |
| Interaction | DTX2 interactions | 3.47e-06 | 330 | 40 | 7 | int:DTX2 | |
| Interaction | SSBP3 interactions | 3.68e-06 | 119 | 40 | 5 | int:SSBP3 | |
| Interaction | WWP2 interactions | TOM1L2 PPP1R13B EWSR1 TSG101 ARID1B RUNX2 SUPT5H POLR2A HGS YLPM1 | 4.07e-06 | 840 | 40 | 10 | int:WWP2 |
| Interaction | CIITA interactions | 4.22e-06 | 55 | 40 | 4 | int:CIITA | |
| Interaction | PITX1 interactions | 5.06e-06 | 127 | 40 | 5 | int:PITX1 | |
| Interaction | CIC interactions | 5.29e-06 | 673 | 40 | 9 | int:CIC | |
| Interaction | SMARCC2 interactions | 5.40e-06 | 353 | 40 | 7 | int:SMARCC2 | |
| Interaction | EYA4 interactions | 7.87e-06 | 243 | 40 | 6 | int:EYA4 | |
| Interaction | FAM168A interactions | 8.73e-06 | 142 | 40 | 5 | int:FAM168A | |
| Interaction | PIN1 interactions | 9.20e-06 | 383 | 40 | 7 | int:PIN1 | |
| Interaction | BICRA interactions | 9.32e-06 | 67 | 40 | 4 | int:BICRA | |
| Interaction | GPS2 interactions | 9.35e-06 | 144 | 40 | 5 | int:GPS2 | |
| Interaction | NEDD4 interactions | 9.62e-06 | 544 | 40 | 8 | int:NEDD4 | |
| Interaction | CEP55 interactions | 1.06e-05 | 256 | 40 | 6 | int:CEP55 | |
| Interaction | TLE6 interactions | 1.62e-05 | 25 | 40 | 3 | int:TLE6 | |
| Interaction | PTPN23 interactions | 1.65e-05 | 162 | 40 | 5 | int:PTPN23 | |
| Interaction | CSTF2 interactions | 1.81e-05 | 165 | 40 | 5 | int:CSTF2 | |
| Interaction | CREBBP interactions | 1.93e-05 | 599 | 40 | 8 | int:CREBBP | |
| Interaction | PDLIM4 interactions | 2.05e-05 | 27 | 40 | 3 | int:PDLIM4 | |
| Interaction | UBQLN2 interactions | 2.05e-05 | 797 | 40 | 9 | int:UBQLN2 | |
| Interaction | SOX7 interactions | 2.08e-05 | 82 | 40 | 4 | int:SOX7 | |
| Interaction | PYGO1 interactions | 2.29e-05 | 28 | 40 | 3 | int:PYGO1 | |
| Interaction | BCL9 interactions | 2.51e-05 | 86 | 40 | 4 | int:BCL9 | |
| Interaction | GSC interactions | 2.63e-05 | 87 | 40 | 4 | int:GSC | |
| Interaction | TSG101 interactions | 2.74e-05 | 303 | 40 | 6 | int:TSG101 | |
| Interaction | SP7 interactions | 2.80e-05 | 304 | 40 | 6 | int:SP7 | |
| Interaction | SMARCA4 interactions | 3.08e-05 | 462 | 40 | 7 | int:SMARCA4 | |
| Interaction | ATN1 interactions | 3.30e-05 | 187 | 40 | 5 | int:ATN1 | |
| Interaction | QKI interactions | 3.56e-05 | 190 | 40 | 5 | int:QKI | |
| Interaction | SS18L1 interactions | 4.20e-05 | 98 | 40 | 4 | int:SS18L1 | |
| Interaction | GATA2 interactions | 4.44e-05 | 199 | 40 | 5 | int:GATA2 | |
| Interaction | NSMF interactions | 4.54e-05 | 35 | 40 | 3 | int:NSMF | |
| Interaction | DTNB interactions | 4.73e-05 | 101 | 40 | 4 | int:DTNB | |
| Interaction | ZSWIM4 interactions | 5.73e-05 | 6 | 40 | 2 | int:ZSWIM4 | |
| Interaction | PEF1 interactions | 6.14e-05 | 108 | 40 | 4 | int:PEF1 | |
| Interaction | TP53BP1 interactions | 7.61e-05 | 533 | 40 | 7 | int:TP53BP1 | |
| Interaction | FAM222B interactions | 7.88e-05 | 42 | 40 | 3 | int:FAM222B | |
| Interaction | CEBPB interactions | CARM1 AGFG1 EWSR1 TSG101 RUNX2 EGR1 SUPT5H NFIC POLR2A ANXA11 YLPM1 | 8.13e-05 | 1443 | 40 | 11 | int:CEBPB |
| Interaction | ALG2 interactions | 9.07e-05 | 44 | 40 | 3 | int:ALG2 | |
| Interaction | MAPK1IP1L interactions | 9.70e-05 | 45 | 40 | 3 | int:MAPK1IP1L | |
| Interaction | RFX3 interactions | 9.70e-05 | 45 | 40 | 3 | int:RFX3 | |
| Interaction | SMARCC1 interactions | 1.02e-04 | 384 | 40 | 6 | int:SMARCC1 | |
| Interaction | PAX7 interactions | 1.05e-04 | 124 | 40 | 4 | int:PAX7 | |
| Interaction | ERCC8 interactions | 1.05e-04 | 124 | 40 | 4 | int:ERCC8 | |
| Interaction | SMAD1 interactions | 1.14e-04 | 243 | 40 | 5 | int:SMAD1 | |
| Interaction | BCL9L interactions | 1.18e-04 | 48 | 40 | 3 | int:BCL9L | |
| Interaction | CCNK interactions | 1.34e-04 | 132 | 40 | 4 | int:CCNK | |
| Interaction | SUPT5H interactions | 1.42e-04 | 408 | 40 | 6 | int:SUPT5H | |
| Interaction | TFG interactions | 1.51e-04 | 258 | 40 | 5 | int:TFG | |
| Interaction | WWP1 interactions | 1.56e-04 | 260 | 40 | 5 | int:WWP1 | |
| Interaction | LHX8 interactions | 1.58e-04 | 53 | 40 | 3 | int:LHX8 | |
| Interaction | WWTR1 interactions | 1.71e-04 | 422 | 40 | 6 | int:WWTR1 | |
| Interaction | SOX15 interactions | 1.73e-04 | 141 | 40 | 4 | int:SOX15 | |
| Interaction | VPS37C interactions | 1.73e-04 | 141 | 40 | 4 | int:VPS37C | |
| Interaction | HSF1 interactions | 1.74e-04 | 609 | 40 | 7 | int:HSF1 | |
| Interaction | NUP35 interactions | 1.75e-04 | 424 | 40 | 6 | int:NUP35 | |
| Interaction | VPS37B interactions | 1.97e-04 | 57 | 40 | 3 | int:VPS37B | |
| Interaction | NCOA1 interactions | 1.97e-04 | 146 | 40 | 4 | int:NCOA1 | |
| Interaction | STAM2 interactions | 2.02e-04 | 147 | 40 | 4 | int:STAM2 | |
| Interaction | FHL3 interactions | 2.07e-04 | 276 | 40 | 5 | int:FHL3 | |
| Interaction | ARID1A interactions | 2.07e-04 | 276 | 40 | 5 | int:ARID1A | |
| Interaction | WWOX interactions | 2.08e-04 | 627 | 40 | 7 | int:WWOX | |
| Interaction | EYA1 interactions | 2.18e-04 | 59 | 40 | 3 | int:EYA1 | |
| Interaction | BAG3 interactions | 2.18e-04 | 632 | 40 | 7 | int:BAG3 | |
| Interaction | TLE5 interactions | 2.22e-04 | 443 | 40 | 6 | int:TLE5 | |
| Interaction | LMO3 interactions | 2.30e-04 | 152 | 40 | 4 | int:LMO3 | |
| Interaction | SMAD3 interactions | 2.33e-04 | 447 | 40 | 6 | int:SMAD3 | |
| Interaction | GSE1 interactions | 2.42e-04 | 154 | 40 | 4 | int:GSE1 | |
| Interaction | LMO1 interactions | 2.42e-04 | 154 | 40 | 4 | int:LMO1 | |
| Interaction | SMARCE1 interactions | 2.47e-04 | 287 | 40 | 5 | int:SMARCE1 | |
| Interaction | ZDHHC6 interactions | 2.53e-04 | 62 | 40 | 3 | int:ZDHHC6 | |
| Interaction | HES1 interactions | 2.78e-04 | 64 | 40 | 3 | int:HES1 | |
| Interaction | PATZ1 interactions | 3.00e-04 | 163 | 40 | 4 | int:PATZ1 | |
| Interaction | SUPT4H1 interactions | 3.18e-04 | 67 | 40 | 3 | int:SUPT4H1 | |
| Interaction | LHX4 interactions | 3.22e-04 | 166 | 40 | 4 | int:LHX4 | |
| Interaction | HSPBP1 interactions | 3.22e-04 | 166 | 40 | 4 | int:HSPBP1 | |
| Interaction | SF1 interactions | 3.23e-04 | 304 | 40 | 5 | int:SF1 | |
| Interaction | NFKB1 interactions | 3.37e-04 | 307 | 40 | 5 | int:NFKB1 | |
| Interaction | IDI2 interactions | 3.44e-04 | 14 | 40 | 2 | int:IDI2 | |
| Interaction | DAZAP1 interactions | 3.45e-04 | 169 | 40 | 4 | int:DAZAP1 | |
| Interaction | KMT2D interactions | 3.45e-04 | 169 | 40 | 4 | int:KMT2D | |
| Interaction | SNRPA interactions | 3.49e-04 | 482 | 40 | 6 | int:SNRPA | |
| Interaction | FOS interactions | 3.63e-04 | 312 | 40 | 5 | int:FOS | |
| Interaction | EPAS1 interactions | 3.77e-04 | 173 | 40 | 4 | int:EPAS1 | |
| Interaction | TLX1 interactions | 3.93e-04 | 175 | 40 | 4 | int:TLX1 | |
| Interaction | TEAD1 interactions | 4.02e-04 | 176 | 40 | 4 | int:TEAD1 | |
| Interaction | POLR2G interactions | 4.28e-04 | 179 | 40 | 4 | int:POLR2G | |
| Interaction | RUNX1 interactions | 4.32e-04 | 324 | 40 | 5 | int:RUNX1 | |
| Interaction | SERGEF interactions | 4.53e-04 | 16 | 40 | 2 | int:SERGEF | |
| Interaction | CELA2A interactions | 4.53e-04 | 16 | 40 | 2 | int:CELA2A | |
| Interaction | LHX2 interactions | 4.66e-04 | 183 | 40 | 4 | int:LHX2 | |
| Interaction | TNIP2 interactions | 4.81e-04 | 952 | 40 | 8 | int:TNIP2 | |
| Interaction | LHX3 interactions | 4.85e-04 | 185 | 40 | 4 | int:LHX3 | |
| Interaction | XRCC5 interactions | 4.96e-04 | 515 | 40 | 6 | int:XRCC5 | |
| Interaction | SNRPB interactions | 5.06e-04 | 517 | 40 | 6 | int:SNRPB | |
| Interaction | PELP1 interactions | 5.26e-04 | 189 | 40 | 4 | int:PELP1 | |
| Interaction | SAXO4 interactions | 5.35e-04 | 80 | 40 | 3 | int:SAXO4 | |
| Cytoband | 2p13.1 | 4.08e-04 | 34 | 40 | 2 | 2p13.1 | |
| GeneFamily | AT-rich interaction domain containing | 2.76e-04 | 15 | 30 | 2 | 418 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 3.28e-03 | 181 | 30 | 3 | 694 | |
| GeneFamily | LIM domain containing | 4.29e-03 | 59 | 30 | 2 | 1218 | |
| GeneFamily | RNA binding motif containing | 5.18e-03 | 213 | 30 | 3 | 725 | |
| Coexpression | GSE9946_IMMATURE_VS_PROSTAGLANDINE2_TREATED_MATURE_DC_UP | 3.32e-06 | 151 | 40 | 5 | M421 | |
| Coexpression | LAKE_ADULT_KIDNEY_C27_VASCULAR_SMOOTH_MUSCLE_CELLS_AND_PERICYTES | 3.77e-06 | 155 | 40 | 5 | M39246 | |
| Coexpression | GSE22229_RENAL_TRANSPLANT_VS_HEALTHY_PBMC_DN | 1.24e-05 | 198 | 40 | 5 | M7480 | |
| Coexpression | UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN | 2.27e-05 | 36 | 40 | 3 | M9162 | |
| Coexpression | TERAO_AOX4_TARGETS_HG_DN | 3.39e-05 | 6 | 40 | 2 | M2361 | |
| Coexpression | BENPORATH_ES_WITH_H3K27ME3 | 3.67e-05 | 1115 | 40 | 9 | M10371 | |
| Coexpression | TERAO_AOX4_TARGETS_HG_DN | 4.75e-05 | 7 | 40 | 2 | MM923 | |
| Coexpression | GSE12963_UNINF_VS_ENV_AND_NEF_DEFICIENT_HIV1_INF_CD4_TCELL_UP | 6.31e-05 | 141 | 40 | 4 | M449 | |
| Coexpression | TABULA_MURIS_SENIS_MESENTERIC_ADIPOSE_TISSUE_MESENCHYMAL_STEM_CELL_OF_ADIPOSE_AGEING | 7.11e-05 | 685 | 40 | 7 | MM3782 | |
| Coexpression | HALLMARK_DNA_REPAIR | 8.02e-05 | 150 | 40 | 4 | M5898 | |
| Coexpression | LOPEZ_MBD_TARGETS | 8.10e-05 | 953 | 40 | 8 | M4120 | |
| Coexpression | MARSON_BOUND_BY_FOXP3_UNSTIMULATED | TOM1L2 MPLKIP PPP1R13B EWSR1 SSBP3 NFATC3 POLR2A YLPM1 ARID5B | 8.30e-05 | 1239 | 40 | 9 | M1743 |
| Coexpression | GAUTAM_EYE_CORNEA_ELF3_HIGH_EPITHELIAL_CELLS | 8.44e-05 | 152 | 40 | 4 | M43614 | |
| Coexpression | MARSON_BOUND_BY_FOXP3_UNSTIMULATED | TOM1L2 MPLKIP PPP1R13B EWSR1 SSBP3 NFATC3 POLR2A YLPM1 ARID5B | 1.05e-04 | 1277 | 40 | 9 | MM1032 |
| Coexpression | GSE37301_HEMATOPOIETIC_STEM_CELL_VS_GRAN_MONO_PROGENITOR_UP | 1.08e-04 | 162 | 40 | 4 | M8883 | |
| Coexpression | TABULA_MURIS_SENIS_MAMMARY_GLAND_BASAL_CELL_AGEING | 1.25e-04 | 322 | 40 | 5 | MM3786 | |
| Coexpression | GSE6259_33D1_POS_VS_DEC205_POS_FLT3L_INDUCED_SPLENIC_DC_UP | 1.45e-04 | 175 | 40 | 4 | M6723 | |
| Coexpression | LAKE_ADULT_KIDNEY_C26_MESANGIAL_CELLS | 1.52e-04 | 177 | 40 | 4 | M39245 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_DN | 1.61e-04 | 542 | 40 | 6 | M19529 | |
| Coexpression | GSE10422_WT_VS_BAFF_TRANSGENIC_LN_BCELL_UP | 1.62e-04 | 180 | 40 | 4 | M357 | |
| Coexpression | XIE_TRASTUZUMAB_CARDIOTOXICITY_MMU_MIR_669C_3P_GENES | 1.73e-04 | 183 | 40 | 4 | MM17506 | |
| Coexpression | GSE13485_DAY1_VS_DAY21_YF17D_VACCINE_PBMC_UP | 2.03e-04 | 191 | 40 | 4 | M3298 | |
| Coexpression | IVANOVA_HEMATOPOIESIS_STEM_CELL | 2.12e-04 | 193 | 40 | 4 | M6813 | |
| Coexpression | IVANOVA_HEMATOPOIESIS_STEM_CELL | 2.24e-04 | 196 | 40 | 4 | MM667 | |
| Coexpression | GSE18281_SUBCAPSULAR_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_UP | 2.38e-04 | 199 | 40 | 4 | M7254 | |
| Coexpression | GSE3982_DC_VS_EFF_MEMORY_CD4_TCELL_UP | 2.38e-04 | 199 | 40 | 4 | M5474 | |
| Coexpression | GSE22103_UNSTIM_VS_GMCSF_AND_IFNG_STIM_NEUTROPHIL_UP | 2.42e-04 | 200 | 40 | 4 | M7789 | |
| Coexpression | GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_16H_UP | 2.42e-04 | 200 | 40 | 4 | M8258 | |
| Coexpression | GSE43956_WT_VS_SGK1_KO_TH17_DIFFERENTIATED_CD4_TCELL_DN | 2.42e-04 | 200 | 40 | 4 | M9628 | |
| Coexpression | GSE36078_UNTREATED_VS_AD5_T425A_HEXON_INF_MOUSE_LUNG_DC_UP | 2.42e-04 | 200 | 40 | 4 | M9293 | |
| Coexpression | GSE37301_MULTIPOTENT_PROGENITOR_VS_GRAN_MONO_PROGENITOR_DN | 2.42e-04 | 200 | 40 | 4 | M8849 | |
| Coexpression | GROSS_HYPOXIA_VIA_ELK3_UP | 2.92e-04 | 210 | 40 | 4 | M1303 | |
| Coexpression | GROSS_HYPOXIA_VIA_ELK3_UP | 3.08e-04 | 213 | 40 | 4 | MM1125 | |
| Coexpression | KIM_WT1_TARGETS_UP | 3.31e-04 | 217 | 40 | 4 | M9128 | |
| Coexpression | TOMIDA_METASTASIS_DN | 3.42e-04 | 18 | 40 | 2 | M2583 | |
| Coexpression | DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_VASCULAR_SMOOTH_MUSCLE_CELLS | 3.88e-04 | 93 | 40 | 3 | M39279 | |
| Coexpression | BROWNE_HCMV_INFECTION_10HR_UP | 4.53e-04 | 98 | 40 | 3 | M15382 | |
| Coexpression | TIAN_TNF_SIGNALING_NOT_VIA_NFKB | 5.15e-04 | 22 | 40 | 2 | M14666 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_FIBROBLAST_OF_CARDIAC_TISSUE_AGEING | 5.15e-04 | 244 | 40 | 4 | MM3706 | |
| Coexpression | GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN | 5.39e-04 | 104 | 40 | 3 | M1318 | |
| Coexpression | GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN | 5.85e-04 | 107 | 40 | 3 | MM1130 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_top-relative-expression-ranked_100 | 2.56e-05 | 91 | 40 | 4 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_k-means-cluster#4_top-relative-expression-ranked_100 | 7.22e-05 | 7 | 40 | 2 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_100_k4 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#1_top-relative-expression-ranked_1000 | 8.43e-05 | 240 | 40 | 5 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k1_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_500 | 1.39e-04 | 428 | 40 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_emap-30875_k-means-cluster#2_top-relative-expression-ranked_100 | 1.88e-04 | 11 | 40 | 2 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_100_k2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#4 | 1.98e-04 | 655 | 40 | 7 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K4 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.69e-07 | 186 | 40 | 5 | bd1185592aedebccd1007dbf2dd2f549fcdf9f42 | |
| ToppCell | droplet-Tongue-nan-3m-Epithelial-keratinocyte|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.24e-07 | 194 | 40 | 5 | 592e8c4b73ba424a52305ac411ea9c0a2dc44467 | |
| ToppCell | facs-Lung-Endomucin-24m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.96e-06 | 142 | 40 | 4 | 0a87c0d74e281da5dc4f59e09a5e99c62b1ea801 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.44e-05 | 165 | 40 | 4 | 8a82e20c9b1156bb4bbc16f7785abb04458d671b | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.47e-05 | 166 | 40 | 4 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.73e-05 | 173 | 40 | 4 | 5416b092321c7d9b63f0418c60f2402a138355bf | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.16e-05 | 183 | 40 | 4 | 667717366cb181b8a04a347e64f0f5a4dfc6ee7f | |
| ToppCell | droplet-Bladder-nan-3m|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.66e-05 | 193 | 40 | 4 | e55f79bad6888b84b0ad5fccded498b170e3c6dc | |
| ToppCell | droplet-Tongue-nan-3m-Epithelial|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.66e-05 | 193 | 40 | 4 | 07ddb9525b686c31fa7df4286557d1e58f7ead52 | |
| ToppCell | droplet-Bladder-nan-3m-Epithelial|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.71e-05 | 194 | 40 | 4 | b294056f9bdc243263cf36dce7b62564144b9de1 | |
| ToppCell | ILEUM-non-inflamed-(8)_Fibroblast-(8)_Pericytes|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.88e-05 | 197 | 40 | 4 | 608328608cef82adc867a449216839622253d486 | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Late_airway_SMC|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.94e-05 | 198 | 40 | 4 | 2d0c14f8cabab99bc6d7c27685437c78841c7245 | |
| ToppCell | Control-B_intermediate-0|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.94e-05 | 198 | 40 | 4 | 97e66b845053201247e2241739328cd73f33975c | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblast-(8)_Pericytes|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.94e-05 | 198 | 40 | 4 | 5e274c5597d8720290d452465f0bd40637cb3f27 | |
| ToppCell | Control-B_intermediate-0|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.94e-05 | 198 | 40 | 4 | 6f7e0b8bc06368d6e7026d69473ddd42dd41cfcb | |
| ToppCell | 368C-Fibroblasts-Fibroblast-D-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.00e-05 | 199 | 40 | 4 | 8766796041965a1ba40ad7abdbc244bf1418c209 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-D|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.00e-05 | 199 | 40 | 4 | d39b40d84c72bdde756b805063317ecfad3784f8 | |
| ToppCell | PBMC-Control-Hematopoietic-RBC-RBC-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.54e-04 | 116 | 40 | 3 | 3a11fde2b0a0dad26f6876a3ab3949edfb8b97e2 | |
| ToppCell | PBMC-Control-Hematopoietic-RBC-RBC|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.54e-04 | 116 | 40 | 3 | c1a8d8068efb0e6b88f230df351094b69a4e56e2 | |
| ToppCell | PBMC-Control-Hematopoietic-RBC|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.54e-04 | 116 | 40 | 3 | ca72dfb23c3335cb6bb0d1be5dc032e044eaff1a | |
| ToppCell | Severe-B_naive-13|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.54e-04 | 116 | 40 | 3 | f81a7c3e9cbf39124232d98e2a3a3e308137f391 | |
| ToppCell | Control-Hematopoietic_R-RBC|Control / Disease group, lineage and cell class | 1.58e-04 | 117 | 40 | 3 | 2f8fa933b76f40d2f07391b0f7394483e25bd642 | |
| ToppCell | Control-Hematopoietic_R|Control / Disease group, lineage and cell class | 1.58e-04 | 117 | 40 | 3 | 48c909e3e068d1da5d39f1cf23a321d5e1f31a74 | |
| ToppCell | PBMC-Control-Hematopoietic-RBC|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.62e-04 | 118 | 40 | 3 | e1fb21a8ec0f7b8b828d12e5dc8b470dbf3dc810 | |
| ToppCell | PBMC-Control-Hematopoietic-RBC-RBC|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.62e-04 | 118 | 40 | 3 | 25d35c13d51a347e305f3a3ce239800cf118848e | |
| ToppCell | PBMC-Control-Hematopoietic-RBC-RBC-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.62e-04 | 118 | 40 | 3 | 68a891a0597d206ad5f66c6e087126f020e972b5 | |
| ToppCell | Nasal_Brush-Epithelial-Club|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.28e-04 | 150 | 40 | 3 | d39d73a1de6a873292d48e469d9403f513045be3 | |
| ToppCell | Nasal_Brush-Epithelial-Club|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.28e-04 | 150 | 40 | 3 | c68645ffcffe524cf1d9736cf72a15b37ed8dc3d | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Lymphocytic-Epcam____proximal_tube_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.82e-04 | 158 | 40 | 3 | 1d78578dc1f8ba43dacdccae1082c0b9d749f64d | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.03e-04 | 161 | 40 | 3 | 82ed45f144a07856fe92d37426c5f92e259a03a9 | |
| ToppCell | COVID-CD8-memory_CD4|COVID / Condition, Cell_class and T cell subcluster | 4.11e-04 | 162 | 40 | 3 | 22b2a32217d357146c117e618813d451510a1801 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L4-L4_IT_VISp_Rspo1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.18e-04 | 163 | 40 | 3 | 431221a41d396b09170476179590eaf8a55266d8 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs_st-18m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.18e-04 | 163 | 40 | 3 | a24db9d266a40f3bffe4f18d277bc269791b4560 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L4|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.18e-04 | 163 | 40 | 3 | 1e8ab00ecc2d2ba35aa6745c0ed38663e26312e8 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.33e-04 | 165 | 40 | 3 | cd8de98af8a1a8a6c81d71fae807cc07f319f4c9 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.33e-04 | 165 | 40 | 3 | 3c8baed838eccb6e720bacb7458f087647dc1222 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.33e-04 | 165 | 40 | 3 | 4f83ac71efc57be3668d8db1e62bad05dc6a5e2b | |
| ToppCell | Posterior_cortex-Hematopoietic-MICROGLIA-MI2(C1qb)-Tmem119|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 4.41e-04 | 166 | 40 | 3 | 063d68f2ffb40770cb4601fa1cb6426ae26f7a37 | |
| ToppCell | Posterior_cortex-Hematopoietic-MICROGLIA-MI2(C1qb)-Tmem119-MICROGLIA_Microglia.C1qb.Tmem119-Junb_(Microglia)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 4.41e-04 | 166 | 40 | 3 | 417cfb207da08fa1a0fd5f2a13c8786628667a8e | |
| ToppCell | Posterior_cortex-Hematopoietic-MICROGLIA-MI2(C1qb)-Tmem119-MICROGLIA_Microglia.C1qb.Tmem119-Junb_(Microglia)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 4.41e-04 | 166 | 40 | 3 | f28d07715e6b00ca2a0df39273c5f569744be5a8 | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell-D175|Adult / Lineage, Cell type, age group and donor | 4.49e-04 | 167 | 40 | 3 | c4e321bb87512ea839f324c92c0f1afea891483f | |
| ToppCell | 10x5'-GI_large-bowel|World / Manually curated celltypes from each tissue | 4.56e-04 | 168 | 40 | 3 | 1290c909655bc37f6b8bf216d18127a21b99e9c0 | |
| ToppCell | COVID-19-Myeloid-MoAM5,_CCL3L1|Myeloid / Condition, Lineage and Cell class | 4.56e-04 | 168 | 40 | 3 | ea465152ea31391b63c02425beafa9a4f51f6703 | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 4.72e-04 | 170 | 40 | 3 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Lymphocytic-T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.81e-04 | 171 | 40 | 3 | 246fc7edcefc47437d1df6029f295aca3b34b2b2 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.81e-04 | 171 | 40 | 3 | ea60d9e9df28ab991fbdb596784b44f6a9fc5827 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Lymphocytic-Ly6g5b+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.81e-04 | 171 | 40 | 3 | 1fb4e11f92b48dc2d6e553c22e2571bbd8c223c6 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.06e-04 | 174 | 40 | 3 | f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d | |
| ToppCell | Control-Epithelial_cells-AT1|Control / group, cell type (main and fine annotations) | 5.06e-04 | 174 | 40 | 3 | 548d7f2b958a2bfd2c95eb049ceaab55a559c77d | |
| ToppCell | Mild-CD4+_T_Exhausted|Mild / Disease group and Cell class | 5.14e-04 | 175 | 40 | 3 | 6df099f37875f2cd63502b732a2e07ebfec50e47 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.31e-04 | 177 | 40 | 3 | a8625d14682183cf77cb51eaf11bc15a3528f586 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.31e-04 | 177 | 40 | 3 | 3645e2f4a48283f290f85c49c3e79e3f58ac9aa6 | |
| ToppCell | facs-Heart-RA-18m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.40e-04 | 178 | 40 | 3 | b505e2550860e777535ee95f29c936242fd607f1 | |
| ToppCell | COVID-19-kidney-vSMC/Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.49e-04 | 179 | 40 | 3 | 111b1084f73306bdeffaaf240e7dbb4f5bf33de1 | |
| ToppCell | (1)_B_cells-(1)_B_CD27pos|(1)_B_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 5.67e-04 | 181 | 40 | 3 | d2476956ca13f9234d7e77c3ee432dd54eebeac4 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell-D175|Adult / Lineage, Cell type, age group and donor | 5.76e-04 | 182 | 40 | 3 | ad4d74d8b19976e1ccc3c5ba8013199338cf6fd8 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.85e-04 | 183 | 40 | 3 | ec2af3402b51f11466d2a5783a6b33746b6a7fc9 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.95e-04 | 184 | 40 | 3 | 57c792e6e2fedba25d3350ffe649fd74750b579d | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.95e-04 | 184 | 40 | 3 | d7bd0f0c607bade67c99e9fb3578a570298bf926 | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.04e-04 | 185 | 40 | 3 | 9faa35ceb89ccd2979072286f063687c9f846ce3 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_5|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.04e-04 | 185 | 40 | 3 | 6bab4fc08bdc3de040bbcc750e1ee30932fcadbe | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_5|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.04e-04 | 185 | 40 | 3 | 2df3e814859c8f468d203f9d84ecc02e0c5788ad | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.14e-04 | 186 | 40 | 3 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | ASK428-Endothelial-Endothelium|Endothelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 6.18e-04 | 41 | 40 | 2 | a72d926de3dc9e420b80764af88002e436517790 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Epithelial-Epithelial,_Airway-secretory_cell-Epi-Secretory|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.23e-04 | 187 | 40 | 3 | 43ef900b76f3c38bd8ce9858201124130c743d56 | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-Pericytes-Pericyte|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.23e-04 | 187 | 40 | 3 | 150023e6a50c9da461f2321074d2d5e96caafb06 | |
| ToppCell | normal_Lung-Myeloid_cells-pDCs|normal_Lung / Location, Cell class and cell subclass | 6.23e-04 | 187 | 40 | 3 | d36751372fd40a46441f07735c9c3c5dcb503f24 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Epithelial-Epithelial,_Airway-secretory_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.23e-04 | 187 | 40 | 3 | 6e5c38425b6b1d4774f8dcea7e146f1eab785c3e | |
| ToppCell | COVID-19-kidney-Fibroblast-1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.23e-04 | 187 | 40 | 3 | 76bfe8c42430a230a8bdf299575c444fb7780f24 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 6.33e-04 | 188 | 40 | 3 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-Trm_Th1/Th17|lymph-node_spleen / Manually curated celltypes from each tissue | 6.33e-04 | 188 | 40 | 3 | a20521198c6db17589535fb439533329582c9dd2 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.33e-04 | 188 | 40 | 3 | f54b063025d80de631382bf5326bc40aab7f7d00 | |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.33e-04 | 188 | 40 | 3 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | 3'-Adult-Distal_Rectal-Mesenchymal-Pericytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.43e-04 | 189 | 40 | 3 | d69b7a01dd4d6ad043bb6210e9ab34b49578389c | |
| ToppCell | 3'-Adult-Distal_Rectal-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.43e-04 | 189 | 40 | 3 | 2b5f1b4f173a224342ea4f10b193ee33b7662699 | |
| ToppCell | 3'-Adult-Distal_Rectal-Mesenchymal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.43e-04 | 189 | 40 | 3 | 43e131458d8a4b120f7a5fb3d0c5650abded15f6 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.43e-04 | 189 | 40 | 3 | 965e0e388251e7318f8b463816dc96ccb4658677 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.53e-04 | 190 | 40 | 3 | 30b50d183d7649146eb1e79b47ba897355f1998a | |
| ToppCell | facs-Large_Intestine-Proximal-24m-Epithelial-intestinal_crypt_stem_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.53e-04 | 190 | 40 | 3 | 933c778bb8ec89621906fe7d484c1d2c6cd28d80 | |
| ToppCell | BAL-Control-Lymphocyte-B-B_cell|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.53e-04 | 190 | 40 | 3 | da7341a8a423e5fe4d8e733d8e50c10a3318ac1c | |
| ToppCell | BAL-Control-Lymphocyte-B-B_cell-B_cell-B_activate-7|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.53e-04 | 190 | 40 | 3 | 682418a7a2096743112eae3790d40e7e600612c0 | |
| ToppCell | BAL-Control-Lymphocyte-B-B_cell-B_cell|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.53e-04 | 190 | 40 | 3 | 42312f7d79fe889397d32910b625793e2535cc26 | |
| ToppCell | COVID-19-kidney-vSMC/Pericyte|kidney / Disease (COVID-19 only), tissue and cell type | 6.63e-04 | 191 | 40 | 3 | fad8eaa536001b911d05ae2b12150c2398cc6f88 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 6.63e-04 | 191 | 40 | 3 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | facs-Trachea-nan-18m-Mesenchymal-fibroblast|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.63e-04 | 191 | 40 | 3 | 783e8c436de90623bb1bc4117270d60c8c8a9461 | |
| ToppCell | facs-Trachea-nan-18m-Mesenchymal|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.73e-04 | 192 | 40 | 3 | ceadfbce037bef15523916ba091bb6c0d752cce5 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-secretory_cell-Epi-Secretory|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.73e-04 | 192 | 40 | 3 | 8899d81306770adda893b5e146df1253971754c5 | |
| ToppCell | facs-Trachea-nan-18m-Mesenchymal-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.73e-04 | 192 | 40 | 3 | f388a336062880609724e91bf51bd0f9c4da2f69 | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | 6.73e-04 | 192 | 40 | 3 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.73e-04 | 192 | 40 | 3 | d0649410cf5eacdb0c1dce70e37c7473ef5fddfa | |
| ToppCell | ILEUM-non-inflamed-(2)_B_cell-(2)_Memory_B_cells|(2)_B_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 6.73e-04 | 192 | 40 | 3 | 37d0d0fdd6bc3114d546020b472b6df9392392f4 | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.73e-04 | 192 | 40 | 3 | 11867f30f0b420c18cb0b34d3990237aa737a0e8 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-secretory_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.73e-04 | 192 | 40 | 3 | 5fda9a465c9f77c7fa1a3ea07a2b0374bbc23b2a | |
| ToppCell | LA-14._Fibroblast_III|LA / Chamber and Cluster_Paper | 6.83e-04 | 193 | 40 | 3 | 7426c291bac59e539c427bcaae18abc7d397d44e | |
| ToppCell | droplet-Tongue-nan-3m|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.83e-04 | 193 | 40 | 3 | cba070019db30604ebddb610eedf92e48221ac58 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.83e-04 | 193 | 40 | 3 | 739fb2a57772a800a2e94bdd6c71285bb2c162a7 | |
| ToppCell | 10x5'-GI_small-bowel|World / Manually curated celltypes from each tissue | 6.83e-04 | 193 | 40 | 3 | cd89dfe53a114078f06343049685883c8e26508f | |
| ToppCell | Control-CD8+_T_naive|Control / Disease condition and Cell class | 6.83e-04 | 193 | 40 | 3 | 627d345baf1940218c61907305705298e473dbab | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.83e-04 | 193 | 40 | 3 | 000b9e6a819b94ea2e6e9173daf97ba9ac2b6cc6 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.83e-04 | 193 | 40 | 3 | dbf0fe496254320c894568c31e5f9ce63707d1b5 | |
| Drug | SAHA; Down 200; 10uM; HL60; HT_HG-U133A | 1.34e-05 | 175 | 40 | 5 | 1161_DN | |
| Drug | Resveratrol [501-36-0]; Up 200; 17.6uM; HL60; HG-U133A | 2.15e-05 | 193 | 40 | 5 | 1715_UP | |
| Drug | Acacetin [480-44-4]; Down 200; 14uM; PC3; HT_HG-U133A | 2.26e-05 | 195 | 40 | 5 | 4324_DN | |
| Drug | rhodioloside | 2.41e-05 | 32 | 40 | 3 | ctd:C009172 | |
| Drug | Methiothepin maleate [19728-88-2]; Down 200; 8.4uM; HL60; HG-U133A | 2.43e-05 | 198 | 40 | 5 | 1616_DN | |
| Drug | 6,7-dimethoxy-2-(pyrrolidin-1-yl)-N-(5-(pyrrolidin-1-yl)pentyl)quinazolin-4-amine | 3.31e-05 | 104 | 40 | 4 | ctd:C000595015 | |
| Drug | A-K-V | 3.74e-05 | 37 | 40 | 3 | CID011840919 | |
| Drug | MT-19 | 6.28e-05 | 7 | 40 | 2 | CID003083507 | |
| Drug | NSC401575 | 7.67e-05 | 129 | 40 | 4 | CID000003165 | |
| Drug | N-((2,2-dimethyl-2,3-dihydrobenzofuran-7-yloxy)ethyl)-3-(cyclopent-1-enyl)benzylamine | 1.08e-04 | 9 | 40 | 2 | ctd:C518313 | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 1.89e-04 | 163 | 40 | 4 | 5594_DN | |
| Drug | AC1L2E0P | 1.93e-04 | 307 | 40 | 5 | CID000019390 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.98e-04 | 165 | 40 | 4 | 2835_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.03e-04 | 166 | 40 | 4 | 7324_DN | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A | 2.08e-04 | 167 | 40 | 4 | 5217_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.17e-04 | 169 | 40 | 4 | 5572_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 2.22e-04 | 170 | 40 | 4 | 1050_DN | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 2.27e-04 | 171 | 40 | 4 | 1000_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.27e-04 | 171 | 40 | 4 | 4954_DN | |
| Drug | difenamizole | 2.32e-04 | 13 | 40 | 2 | CID000065695 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.32e-04 | 172 | 40 | 4 | 3428_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.32e-04 | 172 | 40 | 4 | 2330_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 2.32e-04 | 172 | 40 | 4 | 1072_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.38e-04 | 173 | 40 | 4 | 2084_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 2.43e-04 | 174 | 40 | 4 | 5945_DN | |
| Drug | 2,6-dihydroxybenzoic acid | 2.48e-04 | 175 | 40 | 4 | CID000009338 | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 2.59e-04 | 177 | 40 | 4 | 6551_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.65e-04 | 178 | 40 | 4 | 6276_DN | |
| Drug | GSK126 | 2.70e-04 | 14 | 40 | 2 | ctd:C577920 | |
| Drug | Dipivefrin hydrochloride [64019-93-8]; Up 200; 10.4uM; HL60; HG-U133A | 2.76e-04 | 180 | 40 | 4 | 1752_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.82e-04 | 181 | 40 | 4 | 3643_DN | |
| Drug | Thioguanosine [85-31-4]; Up 200; 12.6uM; MCF7; HT_HG-U133A | 2.88e-04 | 182 | 40 | 4 | 4989_UP | |
| Drug | valinomycin; Up 200; 0.1uM; MCF7; HT_HG-U133A | 3.01e-04 | 184 | 40 | 4 | 5957_UP | |
| Drug | Diethylstilbestrol [56-53-1]; Up 200; 15uM; MCF7; HT_HG-U133A | 3.01e-04 | 184 | 40 | 4 | 4369_UP | |
| Drug | (1-[(4-Chlorophenyl)phenyl-methyl]-4-methylpiperazine) [1620-21-9]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 3.07e-04 | 185 | 40 | 4 | 3893_UP | |
| Drug | D-threonohydroxamic acid | 3.11e-04 | 15 | 40 | 2 | CID000449343 | |
| Drug | Cosopt | 3.13e-04 | 341 | 40 | 5 | CID000003154 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 3.20e-04 | 187 | 40 | 4 | 4302_DN | |
| Drug | Tetrandrine [518-34-3]; Up 200; 6.4uM; PC3; HT_HG-U133A | 3.33e-04 | 189 | 40 | 4 | 5821_UP | |
| Drug | Cloperastine hydrochloride [14984-68-0]; Down 200; 11uM; PC3; HT_HG-U133A | 3.33e-04 | 189 | 40 | 4 | 4271_DN | |
| Drug | Clioquinol [130-26-7]; Up 200; 13uM; HL60; HT_HG-U133A | 3.33e-04 | 189 | 40 | 4 | 3084_UP | |
| Drug | Chlorpheniramine maleate [113-92-8]; Down 200; 10.2uM; PC3; HT_HG-U133A | 3.46e-04 | 191 | 40 | 4 | 2055_DN | |
| Drug | Dimethisoquin hydrochloride [2773-92-4]; Up 200; 13uM; MCF7; HT_HG-U133A | 3.46e-04 | 191 | 40 | 4 | 4791_UP | |
| Drug | aldosterone-18-glucuronide | 3.56e-04 | 16 | 40 | 2 | CID000160706 | |
| Drug | MEK1/2 inhibitor | 3.60e-04 | 193 | 40 | 4 | CID009549284 | |
| Drug | Forskolin, from Coleus forskohlii; Down 200; 0.5uM; PC3; HT_HG-U133A | 3.60e-04 | 193 | 40 | 4 | 7059_DN | |
| Drug | troglitazone; Up 200; 10uM; MCF7; HT_HG-U133A | 3.60e-04 | 193 | 40 | 4 | 1657_UP | |
| Drug | Chlorthalidone [77-36-1]; Down 200; 11.8uM; HL60; HG-U133A | 3.67e-04 | 194 | 40 | 4 | 1581_DN | |
| Drug | Moricizine hydrochloride [31883-05-3]; Up 200; 8.6uM; HL60; HT_HG-U133A | 3.67e-04 | 194 | 40 | 4 | 2959_UP | |
| Drug | Methoxy-6-harmalan [3589-73-9]; Up 200; 18.6uM; MCF7; HT_HG-U133A | 3.67e-04 | 194 | 40 | 4 | 2893_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HG-U133A | 3.75e-04 | 195 | 40 | 4 | 1561_DN | |
| Drug | 3-Acetylcoumarin [3949-36-8]; Down 200; 21.2uM; PC3; HT_HG-U133A | 3.75e-04 | 195 | 40 | 4 | 4664_DN | |
| Drug | SR-95639A [115767-94-7]; Down 200; 10uM; HL60; HT_HG-U133A | 3.75e-04 | 195 | 40 | 4 | 1336_DN | |
| Drug | Torsemide [56211-40-6]; Down 200; 11.4uM; HL60; HT_HG-U133A | 3.75e-04 | 195 | 40 | 4 | 2956_DN | |
| Drug | AC1L9LNU | 3.76e-04 | 80 | 40 | 3 | CID000448157 | |
| Drug | Methylprednisolone, 6-alpha [83-43-2]; Down 200; 10.6uM; HL60; HG-U133A | 3.82e-04 | 196 | 40 | 4 | 1567_DN | |
| Drug | sodium 4-phenylbutyrate; Down 200; 100uM; MCF7; HG-U133A | 3.82e-04 | 196 | 40 | 4 | 341_DN | |
| Drug | Dosulepin hydrochloride [897-15-4]; Up 200; 12uM; HL60; HG-U133A | 3.82e-04 | 196 | 40 | 4 | 1713_UP | |
| Drug | Deptropine citrate [2169-75-7]; Up 200; 7.6uM; HL60; HT_HG-U133A | 3.82e-04 | 196 | 40 | 4 | 3144_UP | |
| Drug | Piracetam [7491-74-9]; Up 200; 28.2uM; PC3; HT_HG-U133A | 3.89e-04 | 197 | 40 | 4 | 5043_UP | |
| Drug | fluphenazine dihydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 3.89e-04 | 197 | 40 | 4 | 1075_DN | |
| Drug | Ungerine nitrate; Down 200; 10.2uM; HL60; HT_HG-U133A | 3.89e-04 | 197 | 40 | 4 | 2514_DN | |
| Drug | Benfotiamine [22457-89-2]; Up 200; 8.6uM; HL60; HT_HG-U133A | 3.89e-04 | 197 | 40 | 4 | 2177_UP | |
| Drug | Medrysone [2668-66-8]; Down 200; 11.6uM; PC3; HT_HG-U133A | 3.89e-04 | 197 | 40 | 4 | 4266_DN | |
| Drug | prochlorperazine dimaleate salt; Down 200; 10uM; PC3; HT_HG-U133A | 3.89e-04 | 197 | 40 | 4 | 1215_DN | |
| Drug | Fluphenazine dihydrochloride [146-56-5]; Down 200; 7.8uM; HL60; HG-U133A | 3.89e-04 | 197 | 40 | 4 | 1577_DN | |
| Drug | Chlorprothixene hydrochloride [6469-93-8]; Down 200; 11.4uM; HL60; HT_HG-U133A | 3.97e-04 | 198 | 40 | 4 | 1272_DN | |
| Drug | Mafenide hydrochloride [138-37-4]; Up 200; 18uM; PC3; HT_HG-U133A | 3.97e-04 | 198 | 40 | 4 | 2124_UP | |
| Drug | Naltrexone hydrochloride dihydrate [16676-29-2]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 3.97e-04 | 198 | 40 | 4 | 6241_DN | |
| Drug | Nifedipine [21829-25-4]; Down 200; 11.6uM; PC3; HT_HG-U133A | 3.97e-04 | 198 | 40 | 4 | 7303_DN | |
| Drug | SR-202 | 4.03e-04 | 17 | 40 | 2 | CID000060910 | |
| Drug | dibutyltin dichloride | 4.03e-04 | 17 | 40 | 2 | CID000012688 | |
| Drug | Arcaine sulfate [14923-17-2]; Down 200; 14.8uM; MCF7; HT_HG-U133A | 4.05e-04 | 199 | 40 | 4 | 3349_DN | |
| Drug | Bephenium hydroxynaphthoate [3818-50-6]; Down 200; 9uM; PC3; HT_HG-U133A | 4.05e-04 | 199 | 40 | 4 | 4668_DN | |
| Drug | 0317956-0000 [391210-11-0]; Up 200; 1uM; PC3; HT_HG-U133A | 4.05e-04 | 199 | 40 | 4 | 3777_UP | |
| Drug | Chlorpropamide [94-20-2]; Down 200; 14.4uM; HL60; HG-U133A | 4.12e-04 | 200 | 40 | 4 | 1594_DN | |
| Drug | MP-B | 4.34e-04 | 84 | 40 | 3 | CID000016827 | |
| Drug | AC1L1K2B | 4.52e-04 | 18 | 40 | 2 | CID000005308 | |
| Disease | cortical thickness | 8.67e-05 | 1113 | 39 | 8 | EFO_0004840 | |
| Disease | vital capacity | 1.79e-04 | 1236 | 39 | 8 | EFO_0004312 | |
| Disease | risk-taking behaviour | 4.65e-04 | 764 | 39 | 6 | EFO_0008579 | |
| Disease | Cocaine-Related Disorders | 5.00e-04 | 117 | 39 | 3 | C0236736 | |
| Disease | Cocaine Abuse | 6.35e-04 | 127 | 39 | 3 | C0009171 | |
| Disease | Primary familial dilated cardiomyopathy | 7.23e-04 | 30 | 39 | 2 | cv:C0340427 | |
| Disease | brain measurement, neuroimaging measurement | 7.54e-04 | 550 | 39 | 5 | EFO_0004346, EFO_0004464 | |
| Disease | asthma, seasonal allergic rhinitis | 8.23e-04 | 32 | 39 | 2 | EFO_0003956, MONDO_0004979 | |
| Disease | Cocaine Dependence | 8.26e-04 | 139 | 39 | 3 | C0600427 | |
| Disease | Primary dilated cardiomyopathy | 9.30e-04 | 34 | 39 | 2 | cv:C0007193 | |
| Disease | dilated cardiomyopathy (is_implicated_in) | 1.49e-03 | 43 | 39 | 2 | DOID:12930 (is_implicated_in) | |
| Disease | cortical surface area measurement | 1.72e-03 | 1345 | 39 | 7 | EFO_0010736 | |
| Disease | Cardiomyopathy | 1.77e-03 | 47 | 39 | 2 | cv:C0878544 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PPTSYPPQTGSYSQA | 236 | Q01844 | |
| PVPSYPGYPGSGTVT | 166 | P50995 | |
| PPAYSGVPSASYSGP | 926 | Q8NFD5 | |
| SYGTYPSPTPLGPGS | 461 | Q96KQ4 | |
| GSPYNSRPPSSYGPS | 746 | Q8HWS3 | |
| YLSGPLPPGTYSGPT | 786 | Q9H3S7 | |
| SPYSTVPPYSPGSSG | 206 | Q99811 | |
| YYGSPCSAPSPSTPS | 131 | P22736 | |
| GGSSVPPSPYSTPSY | 621 | Q02779 | |
| PSPGGYPGSYSRSPA | 81 | Q8TAP9 | |
| GANYSPTPYTPSPAP | 421 | O75112 | |
| YTGTTPSPPPGSHYT | 476 | Q86X55 | |
| YPSPVPTSFSSPGSS | 466 | P18146 | |
| PTSFSSPGSSTYPSP | 471 | P18146 | |
| PPTSPGDTAPKYGSY | 246 | Q13724 | |
| SYSPGFSTPQPGQTP | 221 | O95677 | |
| PPAPVSPYSSTCTYG | 966 | Q5VV67 | |
| TSGAVPPYSSSPNPY | 66 | A1KXE4 | |
| YLPPPYPGSSQSQSG | 421 | Q13950 | |
| IPYSSSSPGTYVGPP | 256 | Q9BWW4 | |
| PSGTTSYSQDPPSPS | 706 | O95754 | |
| SPFSYPAPSPSLSSG | 1406 | Q9UPS6 | |
| SPYAAPSPQGSYQPS | 891 | O00267 | |
| GGATSPTSPSYSPPD | 466 | P08651 | |
| SGSYYTAPGSPEPPD | 31 | E7EW31 | |
| TYPNSPASSGPGSPF | 201 | Q99717 | |
| PTGFGTPAPYSLPTS | 471 | P52594 | |
| GASLSSSYPYGSPPP | 701 | Q14865 | |
| PPGGPYPATTSSQYP | 191 | Q99816 | |
| ASPYGGPTPASYTTA | 146 | Q15654 | |
| SPPYGVPTTSTPYEG | 61 | Q96AG3 | |
| IPYSSSSPGSYTGPP | 251 | Q9BWG4 | |
| EPRSPGGYTPQSPSY | 1601 | P24928 | |
| GGYTPQSPSYSPTSP | 1606 | P24928 | |
| SPTSPGYSPTSPTYS | 1941 | P24928 | |
| SPAYYPGLSSPATSP | 1356 | Q9HBL0 | |
| YQPSGPASFPSTFSP | 581 | O14964 | |
| PYQSPSSGTASSPSP | 951 | Q12968 | |
| SPGPGYSSSTTPAAP | 31 | P49750 | |
| PGSTAITPGTPPSYS | 1596 | P11137 | |
| SPPPSSGYDSATPSA | 291 | Q8N9L1 | |
| RTSAGSYSSPPPAPY | 186 | Q6ZVM7 | |
| GYSPSPTHPPTGQYT | 291 | P40225 |